Journal article
Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
- Abstract:
-
Background
There is a high risk of Plasmodium vivax recurrence in patients treated for Plasmodium falciparum malaria in co-endemic areas. Primaquine radical cure has the potential to reduce P vivax recurrences in patients presenting with P falciparum as well as P vivax malaria but is undermined by poor adherence to the currently recommended 14-day regimen. We aimed to assess the efficacy and safety of supervised versus unsupervised primaq... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.1MB, Terms of use)
-
- Publisher copy:
- 10.1016/s1473-3099(21)00358-3
Authors
+ National Health and Medical Research Council
More from this funder
- Funder identifier:
- https://ror.org/011kf5r70
- Grant:
- 1134989
- 1104975
- Funding agency for:
- Simpson, JA
+ Gates Foundation
More from this funder
- Funder identifier:
- https://ror.org/0456r8d26
- Grant:
- INV-007122
+ Department of Foreign Affairs and Trade
More from this funder
- Funder identifier:
- https://ror.org/023wsvq95
- Grant:
- 72904
- Publisher:
- Elsevier
- Journal:
- Lancet Infectious Diseases More from this journal
- Volume:
- 22
- Issue:
- 3
- Pages:
- 367-376
- Publication date:
- 2021-10-25
- DOI:
- EISSN:
-
1474-4457
- ISSN:
-
1473-3099
- Language:
-
English
- Pubs id:
-
1206090
- Local pid:
-
pubs:1206090
- Deposit date:
-
2021-10-30
- ARK identifier:
Terms of use
- Copyright holder:
- Poespoprodjo et al.
- Copyright date:
- 2021
- Rights statement:
- © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record